CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BioPharma Dive
Original article

Shionogi pays $2B to acquire a rare disease startup

Positive
AI Analysis

Summary

Shionogi acquired Texas-based IntraBio for $2B, adding a marketed treatment for two inherited conditions to expand its rare disease portfolio.

Importance:7/10
Sentiment:
0.60
acquisitionrare diseasemarketed treatmentinherited conditions
Related Companies

Read the original article

Published by BioPharma Dive on October 5, 2026 3:57 PM

Read Original